Does the sex of acute stroke patients influence the effectiveness of rt-PA?

[1] Albers GW(1995)Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1581-1587

[2] Bates VE(2000)Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study JAMA 283 1145-1150

[3] Clark WM(2001)Predictors of good outcome after intravenous tPA for acute ischemic stroke Neurology 57 474-480

[4] Bell R(2004)Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator Stroke 35 151-156

[5] Verro P(1997)Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA stroke trial Stroke 28 2119-2125

[6] Hamilton SA(2001)Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement Circulation 103 2897-2902

[7] Demchuk AM(2000)Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke Stroke 31 1812-1816

[8] Tanne D(2001)Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case–control study Stroke 32 2821-2827

[9] Hill MD(2005)Sex differences in stroke care and outcomes; results from the registry of the Canadian stroke network Stroke 36 809-814

[10] Kasner SE(2005)Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischemic stroke in the international stroke trial Neuroepidemiology 24 123-128

[1] Albers GW(1995)Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1581-1587

[2] Bates VE(2000)Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study JAMA 283 1145-1150

[3] Clark WM(2001)Predictors of good outcome after intravenous tPA for acute ischemic stroke Neurology 57 474-480

[4] Bell R(2004)Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator Stroke 35 151-156

[5] Verro P(1997)Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA stroke trial Stroke 28 2119-2125

[6] Hamilton SA(2001)Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement Circulation 103 2897-2902

[7] Demchuk AM(2000)Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke Stroke 31 1812-1816

[8] Tanne D(2001)Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case–control study Stroke 32 2821-2827

[9] Hill MD(2005)Sex differences in stroke care and outcomes; results from the registry of the Canadian stroke network Stroke 36 809-814

[10] Kasner SE(2005)Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischemic stroke in the international stroke trial Neuroepidemiology 24 123-128